Gastroschisis fetal surgery: how doctors repaired a baby's organs before birth

A baby named Theo became the first British infant operated on in the womb to correct complex gastroschisis, a condition in which the intestines develop outside the body through an opening in the abdominal wall, floating in the amniotic fluid surrounding the fetus. The operation was carried out as part of a pioneering clinical trial, and resulted in a birth that the family later described as a 'miracle'.

Gastroschisis is a birth defect in which an opening in the abdominal wall, usually beside the umbilical cord, allows the intestines and sometimes other organs to develop outside the body during pregnancy. It occurs early in gestation, its precise cause remains poorly understood, and it is reported to be somewhat more common among younger mothers.

The traditional approach to treatment is surgery within days of birth to return the organs to the abdominal cavity and close the abdominal wall. Most babies do well with this approach, but so-called 'complex' cases, where the bowel is twisted, blocked, perforated or has a compromised blood supply, are associated with a higher risk of long-term complications, including short bowel syndrome and extended hospital stays.

The rationale for operating before birth rests on a growing body of clinical thinking that prolonged exposure to amniotic fluid, particularly close to full term, can irritate and thicken the exposed bowel, worsening injury in complex cases. The idea behind intervening before delivery is to protect the bowel, or address a complication, before further damage accumulates.

Theo's operation is described as the first of its kind carried out in Britain, and took place as part of a pioneering clinical trial. Doctors and the family called the resulting birth a 'miracle', with the baby reported to have arrived in better condition than the care team had anticipated given the complexity of the abdominal wall defect.

After birth, standard care continues: further monitoring, potential additional surgery, and a stay in a neonatal intensive care unit. Outcomes for babies with gastroschisis have improved substantially over recent decades thanks to advances in specialised surgical and neonatal intensive care, and survival rates in well-resourced health systems are now high, though complex cases remain challenging to treat.

The wider significance of a successful in-womb repair lies in what it could open up for other babies diagnosed prenatally with complex gastroschisis, a condition typically identified through routine ultrasound scans during pregnancy. If the approach proves safe and effective, it could eventually be offered to more expectant parents facing a similar diagnosis.

Fetal surgery in general is a field that requires highly specialised teams, carries risks for both mother and fetus, including preterm labour and infection, and is usually offered only where the anticipated benefit is judged to outweigh those risks, within research trials designed to establish safety and effectiveness before any wider rollout.

Gastroschisis is usually identified during second-trimester scans, giving parents time to be counselled on a delivery plan and the surgical needs their baby is likely to face immediately after birth. Theo's case illustrates the growing role that prenatal diagnosis plays in allowing clinicians to plan earlier interventions rather than waiting until after delivery.

As the pioneering clinical trial continues to enrol and follow further cases, doctors say the approach will need more evaluation before it can be established whether the benefits of in-womb repair outweigh the risks widely enough to become standard care. For now, Theo's case stands as an early milestone in British fetal medicine.